BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28135344)

  • 1. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
    Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
    PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
    Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
    Wang C; Fang Z; Zhu Z; Liu J; Chen H
    Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into iron regulation and erythropoiesis.
    Kim A; Nemeth E
    Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.
    Li H; Choesang T; Bao W; Chen H; Feola M; Garcia-Santos D; Li J; Sun S; Follenzi A; Pham P; Liu J; Zhang J; Ponka P; An X; Mohandas N; Fleming RE; Rivella S; Li G; Ginzburg YZ
    Blood; 2017 Mar; 129(11):1514-1526. PubMed ID: 28151426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
    Olivera J; Zhang V; Nemeth E; Ganz T
    Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroferrone contributes to recovery from anemia of inflammation.
    Kautz L; Jung G; Nemeth E; Ganz T
    Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of erythroferrone as an erythroid regulator of iron metabolism.
    Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
    Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
    Srole DN; Ganz T
    J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
    Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
    J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutual crosstalk between iron and erythropoiesis.
    Camaschella C; Pagani A; Silvestri L; Nai A
    Int J Hematol; 2022 Aug; 116(2):182-191. PubMed ID: 35618957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver.
    Keel SB; Doty R; Liu L; Nemeth E; Cherian S; Ganz T; Abkowitz JL
    Exp Hematol; 2015 Jun; 43(6):469-78.e6. PubMed ID: 25782630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.
    Rybinska I; Cairo G
    Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
    Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutual control of iron and erythropoiesis.
    Camaschella C; Pagani A; Nai A; Silvestri L
    Int J Lab Hematol; 2016 May; 38 Suppl 1():20-6. PubMed ID: 27161430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.